Previous close | 145.76 |
Open | 146.29 |
Bid | 147.47 x 800 |
Ask | 148.65 x 800 |
Day's range | 145.73 - 148.62 |
52-week range | 120.40 - 158.34 |
Volume | |
Avg. volume | 1,078,432 |
Market cap | 16.91B |
Beta (5Y monthly) | 0.97 |
PE ratio (TTM) | 14.57 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.64 (1.81%) |
Ex-dividend date | 17 Jan 2023 |
1y target est | N/A |
LA JOLLA, Calif. & PHOENIX, November 15, 2022--DermTech, Inc. (NASDAQ: DMTK) ("DermTech" or the "Company"), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today an agreement with Sonora Quest Laboratories (Sonora Quest), Arizona’s leading diagnostic laboratory, to expand access to enhanced melanoma detection. As a result of the agreement, Sonora Quest will be the exclusive laboratory in Arizona to offer the DermTech Melanoma Test to its vast network
TORONTO, September 14, 2022--Achievers, an industry-leading employee experience software platform, announces its joint win of a Gold award by Brandon Hall Group with its customer case study of Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services.
PHILADELPHIA & SECAUCUS, N.J., July 19, 2022--Rite Aid (NYSE: RAD) today announced it is collaborating with Quest Diagnostics (NYSE: DGX) to provide access to quality, COVID-19 molecular testing (polymerase chain reaction or similar nucleic acid amplification test) to help Rite Aid customers detect and prevent the spread of COVID-19.